Which medications in the drug class Anticoagulants are used in the treatment of Dysfibrinogenemia?

Updated: Feb 11, 2019
  • Author: Russell Burgess, MD; Chief Editor: Perumal Thiagarajan, MD  more...
  • Print


Prevent recurrent or ongoing thromboembolic occlusion of the vertebrobasilar circulation.


Used in patients with thrombotic tendencies who develop deep venous thrombosis, arterial thrombosis, or pulmonary embolism.

Warfarin (Coumadin)

Interferes with hepatic synthesis of vitamin K–dependent coagulation factors. Used for prophylaxis and treatment of venous thrombosis, pulmonary embolism, and thromboembolic disorders. Tailor dose to maintain an INR in the range of 2-3.

Enoxaparin (Lovenox)

Chronic subcutaneous therapy may be required in patients with recurrent thrombotic episodes.

Enhances inhibition of factor Xa and thrombin by increasing antithrombin III activity. In addition, preferentially increases inhibition of factor Xa.

Average duration of treatment is 7-14 d.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!